Entera Bio

About:

Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel drug delivery platform.

Website: http://www.enterabio.com

Top Investors: Pontifax, Intuitive Venture Partners

Description:

Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user friendly approach to medical treatment. Entera Bio has key personnel with the relevant know how, experience and networks working together to enable rapid development of its products. The company has an experienced management team with more than 50 years of combined drug development experience.

Total Funding Amount:

$30.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2010-01-01

Contact Email:

info(AT)enterabio.com

Founders:

Dr. Phillip Schwartz

Number of Employees:

11-50

Last Funding Date:

2023-12-26

IPO Status:

Public

Industries:

© 2025 bioDAO.ai